phase readout
saveNCT03315455: Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Hemophilia A
view source ↗
comments(0)
5-min edit window · permanent after that